General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Merck and Company(SIGNIFICANT), Roche Diagnostics(SIGNIFICANT), Novartis(SIGNIFICANT), ARCA biopharma, Inc.(MODEST), Inflammatix(MODEST), Abbott(SIGNIFICANT), Regeneron(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT), Johnson & Johnson(SIGNIFICANT), Abbott(SIGNIFICANT), Novartis Pharmaceuticals(SIGNIFICANT), Roche Diagnostics(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Merck and Company(SIGNIFICANT), Daichii Sankyo Ltd(SIGNIFICANT), GlaxoSmithKline(SIGNIFICANT), Eisai Corporation (SIGNIFICANT), Pfizer(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT), Regeneron(SIGNIFICANT), ARCA biopharma, Inc.(SIGNIFICANT), Abiomed(SIGNIFICANT), Siemens Medical Solutions(SIGNIFICANT), SoftCell(SIGNIFICANT)

View Full Disclosure